New Research Evaluates Depression Treatment among Individuals with Dementia and DepressionLed by researchers at the University of Arizona College of Pharmacy and Banner Alzheimer’s Institute, the study aims to better understand and improve depression treatment among older individuals with dementia.
The Science of Consciousness Conference - April 2-7, 2018‘The Science of Consciousness’ Conference will be held from April 2-7, 2018 at Loews Ventana Canyon Resort in Tucson.
UA Startup SinfoníaRx Acquired by Health Care Tech CompanyUniversity of Arizona startup SinfoníaRx, a wholly-owned subsidiary of Sinfonía HealthCare Corporation, has been acquired by Tabula Rasa HealthCare (NASDAQ: TRHC), a public health care company that provides individualized, data-driven technology solutions.
UAHS In The News
Dr. Roberta Diaz Brinton, director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has been named the winner of the 2017 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the Alzheimer's Drug Discovery Foundation (ADDF), is the first to recognize researchers developing treatments for Alzheimer's disease and related dementias.
Tucson-based SinfoníaRx, a spinoff from a University of Arizona College of Pharmacy prescription-management program, has been acquired by a Philadelphia-area company specializing in medication management.
The Valley Fever Center for Excellence (VFCE) at the University of Arizona College of Medicine - Tucson has been awarded a four-year, $4.8 million grant for research to speed development of a vaccine to combat Valley fever, the sometimes deadly respiratory illness caused by Coccidioides spores found in soils of the U.S. Southwest. The funding comes from the National Institute of Allergy and Infectious Diseases (NIAID), a unit of the National Institutes of Health (NIH), and aims to enable development of a live, yet safe, vaccine to prevent this fungal disease (also known as coccidioidomycosis, or cocci).